Evidence map›Paper›PMID 26732809›Full record

ReviewCurrent allergy and asthma reports2016

Innate Immunity: Orchestrating Inflammation and Resolution of Otitis Media.

Arwa Kurabi, Kwang Pak, Allen F Ryan, Stephen I Wasserman

Abstract readReview
In one paragraph

Review in Current allergy and asthma reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Immunomodulation as a Protective Strategy in Chronic Otitis Media.Frontiers in cellular and infection microbiology · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Leukotriene B4 Is a Major Determinant of Leukocyte Recruitment During Otitis Media.Frontiers in cellular and infection microbiology · 2021
    Article
  10. Innate Immunity in the Middle Ear Mucosa.Frontiers in cellular and infection microbiology · 2021
    Review
  11. Article
  12. Nasal Delivery of a CommensalInfection and immunity · 2020
    Article
  13. Vinpocetine SuppressesJournal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  14. Article
  15. Inflammation associated with noise-induced hearing loss.The Journal of the Acoustical Society of America · 2019
    Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Arwa KurabiSchool of Medicine, Department of Surgery, Division of Otolaryngology, University of California San Diego, 9500 Gilman Drive-MC#0666, La Jolla, CA, 92093-0666, USA. akurabi@ucsd.edu.
Kwang PakSchool of Medicine, Department of Surgery, Division of Otolaryngology, University of California San Diego, 9500 Gilman Drive-MC#0666, La Jolla, CA, 92093-0666, USA. kpak@ucsd.edu.
Allen F RyanSchool of Medicine, Department of Surgery, Division of Otolaryngology, University of California San Diego, 9500 Gilman Drive-MC#0666, La Jolla, CA, 92093-0666, USA. afryan@ucsd.edu.
Stephen I WassermanSchool of Medicine-Department of Medicine, Rheumatology, Allergy and Immunology Division, University of California San Diego, 9500 Gilman Drive-MC#0628, La Jolla, CA, 92093-0628, USA. swasserman@ucsd.edu.

Funding

Middle ear responses in Otitis MediaR01DC000129 · NIDCD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI RYAN, ALLEN F. · 1989 to 2021
$6.8M
Innovative therapy for diseases of the middle earR01DC012595 · NIDCD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI RYAN, ALLEN F. · 2012 to 2023
$3.3M
Mechanisms of Persistence and Recovery in Otitis MediaR01DC006279 · NIDCD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WASSERMAN, STEPHEN I · 2003 to 2014
$3.1M
NIDCD NIH HHS DC000129, ,NIDCD NIH HHS DC006279NIDCD NIH HHS DC012595NIDCD NIH HHS R01 DC000129NIDCD NIH HHS R01 DC006279NIDCD NIH HHS R01 DC012595
6 · The paper itself

Abstract

Otitis media (OM) is a common disease in young children, accounting for more office visits and surgeries than any other pediatric condition. It is associated with an estimated cost of five billion dollars annually in the USA. Moreover, chronic and recurrent middle ear (ME) disease leads to hearing loss during critical periods of language acquisition and learning leading to delays in reaching developmental milestones and risking permanent damage to the ME and inner ear in severe cases. Therefore, research to understand the disease pathogenesis and identify new therapeutics is important. Although OM is a multifactorial disease, targeting the molecular mechanisms that drive inflammation and OM resolution is critical. In this review, we discuss the current evidence suggesting that innate immune receptors and effectors play key roles in OM by mediating both the ME inflammatory responses and recovery.

Indexed as

ChildHumansImmunity, InnateInflammationOtitis MediaIL-1ßInflammasomeInflammationInnate immunityMiddle earTLR

Identifiers

PMID26732809
PMCPMC6752202

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.